sipatrigine has been researched along with Acute Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faden, AI; Sun, FY | 1 |
| Dopson, M; Eisenthal, D; Leach, MJ; Nobbs, M; Swan, JH | 1 |
2 other study(ies) available for sipatrigine and Acute Brain Injuries
| Article | Year |
|---|---|
Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injury.
Topics: Animals; Brain Injuries; Cell Death; Hippocampus; Immunohistochemistry; Male; Neurotransmitter Uptake Inhibitors; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Time Factors | 1995 |
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.
Topics: Acetylcholine; Amino Acids; Animals; Blood Pressure; Brain Injuries; Brain Ischemia; Cerebral Cortex; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Heart Rate; Male; Neurotransmitter Agents; Organ Culture Techniques; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Rats, Wistar; Veratrine | 1993 |